期刊文献+

磷酸奥司他韦治疗流行性感冒的疗效分析 被引量:5

Efficacy of Oseltamivir Phosphate in Treatment of Influenza
暂未订购
导出
摘要 目的 观察磷酸奥司他韦治疗流行性感冒的临床疗效,分析该方式治疗流行性感冒的应用价值。方法 选取2015年2月1日~2016年3月31日我院收治的患有流行性感冒的114例患者进行回顾性分析,根据治疗方式分为对照组和观察组,对照组57例患者予以复方感冒灵治疗,观察组57例患者予以磷酸奥司他韦治疗。结果 经治疗对照组总有效率为57.89%(33/57),观察组总有效率为89.47%(51/57)。结论磷酸奥司他韦治疗流行性感冒有较好疗效,值得临床推广。 Objective To duscussthe clinical efficacy of Oseltamivir in treatment of inlfuenza, and analyze the value of the treatment of inlfuenza. MethodsSelected 114 patients suffering from inlfuenza from February 1, 2015 to March 31, 2016 in our hospital were retrospectively analyzed, and according to the treatment divided into control group and observation group. 57 patients in the control group was treated with compound Ganmaoling, and observation group 57 patients was treated with oseltamivir. Results Treated control group, the total effective rate was 57.89% (33/57), and the observation group total effective rate was 89.47% (51/57). Conclusion Phosphate oseltamivirin treatment of inlfuenza has a good effect, worthy of promotion.
作者 周丽华
出处 《中国继续医学教育》 2016年第24期145-146,共2页 China Continuing Medical Education
关键词 磷酸奥司他韦 复方感冒灵 流行性感冒 Oseltamivir phosphate Compound Ganmaoling Inlfuenza
  • 相关文献

参考文献8

二级参考文献46

  • 1苏惠兰,陈爽,陈秀宇,王燕.磷酸奥司他韦颗粒治疗小儿支气管肺炎合并流行性感冒32例的临床观察[J].临床研究,2014,22(4):7-7. 被引量:7
  • 2国家中医药管理局.中药新药临床研究指导原则(试行)[S].北京:中国医药科技出版社,2002.99-104.
  • 3Hayden F G, Fritz R, Lobo M C.Local and systemic cytokine responses during experimental human influenza A virus infection.Relation to syrup tom formation and host defense[J].Journal of Clinical Investigation, 2010, 32(3): 126-127.
  • 4Molecular Diagnostic Methods for Infectious Diseases.Approved Guideline- Second Edition.Clinical and Laboratory Standards Institute (Formerly NCCLS), MM3-A2, Vo126No.8, ISBN 1-56238-596-8.
  • 5李敬芳,朱慧芳.炎虎宁与利巴韦林剂量个体化治疗流行性感冒疗效对比观察[J].中国美容医学,2011,20(z4):105-106.
  • 6冷方南.感冒病临床治疗学[M].北京:中国医药科技出版社,1987:1.
  • 7帕提古力·哈力克.磷酸奥司他韦治疗流感样症状患者的疗效和药理分析[J].中国保健营养(上旬刊),2013,23(6):3239-3240.
  • 8Novel swine-origin influenza A ( H1N1 ) virus investigation. Emer- gence of a novel swine-origin influenza A ( H1N1 ) virus in human [J]. NEnglJMed,2009,360(25):2605-2615.
  • 9U. S. Food and Drug Administration. Review of post-market reports in the adverse event reporting system (AERS) database associated with osehamivir use in pediatricto 16 years patients.
  • 10Teo S S S,Nguyen-Van-Tam J S,Booy R.Influenza burden of illness, diagnosis, treatment, and prevention: what is the evidence in children and where are the gaps?. Archives of Disease in Childhood . 2005

共引文献82

同被引文献25

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部